NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
Back to search
Official data from USPTO
ORUM THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/22/2023
Trademark type
Combined
Nice classes
42
Filing date
08/04/2021
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
03
Owner location
Daejeon, KR
Examiner
HARPER, HANNAH B
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ORUM" in gray font with an orange caret symbol above the letter "U" and the letter "R" stylized without a vertical back element, and with the word "THERAPEUTICS" in smaller gray font below the word "ORUM".
Holders and representatives
Holders
ORUM THERAPEUTICS, INC.
Representatives
Steven J. Hultquist HULTQUIST, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research and development of vaccines and medicines; drug discovery services; research on the subject of pharmaceuticals; pharmaceutical products evaluation; medical laboratory services; scientific research for medical purposes in the field of cancerous and immunological diseases; medical research laboratory services for predicting disease; scientific investigations for medical purposes; pharmaceutical product evaluation; medical product testing; biotechnology research; advisory services relating to biotechnology; research and development in the biotechnology field; biological laboratory services; biological research; development of biologics; design of biologics; research of biologics; biological surveys in the field of pharmaceutical research
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
OTHE
CASE RETURNED TO EXAMINATION
05/01/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/01/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/13/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
03/17/2023
APET
ASSIGNED TO PETITION STAFF
03/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/14/2023
EX1G
SOU EXTENSION 1 GRANTED
03/10/2023
EXT1
SOU EXTENSION 1 FILED
03/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/10/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/02/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/19/2022
PUBO
PUBLISHED FOR OPPOSITION
07/19/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/29/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2022
GNRT
NON-FINAL ACTION E-MAILED
05/03/2022
CNRT
NON-FINAL ACTION WRITTEN
05/03/2022
DOCK
ASSIGNED TO EXAMINER
05/03/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2021
NWAP
NEW APPLICATION ENTERED
08/07/2021
Continuous trademark protection
Get notified about every new filing that threatens ORUM THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.